DNA-based vaccine clears nearly half of precancerous cervical lesions in clinical trial

Using a novel synthetic platform for creating vaccines a team of researchers has successfully eradicated precancerous cervical lesions in nearly half of the women who received an investigational vaccine in a clinical trial.